[ET Net News Agency, 17 July 2024] JD HEALTH (06618) rose 4.3% to HK$21.8, breaking
above the 10-D SMA of HK$21.34.
It hits an intra-day high of HK$21.95, and an intra-day low of HK$20.85. The total
shares traded was 4.11 million, with a value of HK$88.04m. The active buy/sell ratio is
69:31, with net buying turnover of HK$32.86m. TFI SEC & FUTURES accounts for greatest net
responsive buying turnover of HK$1.01m, with volume weighted average price of HK$21.744.
MERRILL LYNCH FE accounts for greatest net responsive selling turnover of HK$7.76m, with
volume weighted average price of HK$21.398.
RMB counter of JD HEALTH (86618) rose 4.7% to RMB20.35.
The Hang Seng Index now rose 2 points, or less than 0.1% to 17,730; the Hang Seng China
Enterprises Index now fell 15 points, or 0.2% to 6,300; the Hang Seng TECH Index now rose
37 points, or 1% to 3,659.

Basic Information
=================

---------------------------------
Nominal 21.800 % Chg +4.31%
High 21.950 Low 20.850
Shares Tr 4.11m Turnover 88.04m
10-D SMA 21.340 %H.V 46.448
20-D SMA 21.940 VWAP 21.413
50-D SMA 25.323 RSI14 43.775
---------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 69:31, with net buying
turnover of HK$32.86m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
JD HEALTH (06618) 21.80 +4.31
ALI HEALTH (00241) 3.42 +8.57
TRAD CHI MED (00570) 3.51 +0.86
CSPC PHARMA (01093) 6.03 +0.67
SINOPHARM (01099) 19.32 +0.52
SINO BIOPHARM (01177) 2.95 +4.61
CHINARES PHARMA (03320) 5.30 Unchanged
HANSOH PHARMA (03692) 17.28 +4.73
GOLDEN THROAT (06896) 3.25 +1.88
JD HEALTH-R (86618) RMB20.35 +4.68
-----------------------------------------------
(ed)